“Profit before saving”: 9 new billionaires exit pharmaceutical corporations from pandemic

The executive directors of Modernna and BioNTech are at the top of the list of nine individuals who became billionaires because of anti-Convid19 vaccines, a group that contributes to the return of the vaccine's concept to public service has said. Most of the scientific research that was done to create effective vaccines against Avid-19 has been paid [...]
Most of the scientific research that was done in the creation of effective vaccines against Avid-19 was paid by taxpayers' money, but private companies holding monopolies in intellectual rights are those who have received the rewards. That situation is unfair and deserves change, they have argued by the People's Vaccines Alliance.
The updated Forbes data in April shows that nine figures of giant pharmaceutical companies have become dollar billionaires since the beginning of the pandemic, writes RT, translates Periscopi.
Modernna Executive Director Stephanie Bancel is the youngest billionaire “vaccine”, but the richest one followed by Ugur Sahin, his counterpart from BioNTech. Everyone now is worth over $4 billion.
The others include three investors in Modernna, the leader of a firm that contracted production and packing of Modernna products, and three cofounders of Chinese vaccine Can Sino Bilogics.
These billionaires are the human face of huge benefits that pharmaceutical corporations are making from the monopolies they hold in these vaccines,” said Anna Marriot, health policy managers at the Oxford charity. /Periscope











